Semin Immunopathol
Seminars in Immunopathology
1863-2297
1863-2300
Springer-Verlag
Berlin/Heidelberg


2315689
18305941
106
10.1007/s00281-008-0106-7
Review


Mechanisms of leukocyte migration across the blood–retina barrier

Crane
Isabel J.



Liversidge
Janet

+44-1224-559548
+44-1224-555955
J.LIVERSIDGE@abdn.ac.uk



School of Medicine, University of Aberdeen Institute of Medical Sciences, Foresterhill, Aberdeen, AB25 2ZD Scotland UK 

28
2
2008

4
2008

30
2
165
177
10
12
2007

4
2
2008


© The Author(s) 2008

Immune-mediated inflammation in the retina is regulated by a combination of anatomical, physiological and immuno-regulatory mechanisms, referred to as the blood–retina barrier (BRB). The BRB is thought to be part of the specialised ocular microenvironment that confers protection or “immune privilege” by deviating or suppressing destructive inflammation. The barrier between the blood circulation and the retina is maintained at two separate anatomical sites. These are the endothelial cells of the inner retinal vasculature and the retinal pigment epithelial cells on Bruch’s membrane between the fenestrated choroidal vessels and the outer retina. The structure and regulation of the tight junctions forming the physical barrier are described. For leukocyte migration across the BRB to occur, changes are needed in both the leukocytes themselves and the cells forming the barrier. We review how the blood–retina barrier is compromised in various inflammatory diseases and discuss the mechanisms controlling leukocyte subset migration into the retina in uveoretinitis in more detail. In particular, we examine the relative roles of selectins and integrins in leukocyte interactions with the vascular endothelium and the pivotal role of chemokines in selective recruitment of leukocyte subsets, triggering adhesion, diapedesis and migration of inflammatory cells into the retinal tissue.

Keywords
Blood–retina barrier
Retinal pigment epithelium
Selectins
Integrins
Chemokines
Tight junctions
Leukocytes
Lymphocytes
Monocytes
Inflammation
Uveitis

issue-copyright-statement
© Springer-Verlag 2008




Introduction
120
121
15
99
76
72
].
9
137
1
]. However, there are also important differences between the tissues, including vascular heterogeneity in the brain and numbers of microglia in the retina.
1
12
45
Fig. 1
1
2
3
4
5
Ve signal?
Ve signal?
) of the inflammatory response




53
].

Leukocyte adhesion cascade
Adhesion molecules in the leukocyte adhesion cascade
82
119
89
44
59
6
78
87
113
126
] or the transcellular route via small continuous membrane associated structures or vesiculo-vacuolar organelles.

Chemokines in the leukocyte adhesion cascade
109
92
7
143
]. The two main groups of chemokines are now designated either CCL, where there is no amino acid separating the cysteines, or CXCL, where there is one amino acid between the cysteine molecules.
32
130
77
111
13
], plus the cell type and the local microenvironment ensure that the chemokine communication system can deliver a precise and accurate communication message to the required cell based on local circumstances, which may be rapidly changing.
110
124
95
96
5
104
].
6
20
26
74
129
23
24
142
24
].


Normal retina and immune surveillance
15
99
].
Structure and function of the blood–retina barrier
53
1
4
132
134
].
1
46
102
33
90
98
46
63
].

Leukocyte infiltration of normal retina
135
137
103
139
65
66
5
138
68
101
103
].


Leukocyte infiltration of the retina during inflammation
21
88
11
14
46
].
Angiogenesis and inflammation
64
70
15
120
].
69
105
52
56
97
].
57
128
80
N
l
l
-NAME) and absent in the iNOS knock-out diabetic mouse.

Leukocyte infiltration of the retina in uveoretinitis
49
].
17
50
38
83
5
16
17
50
103
114
122
18
].


Mechanisms of leukocyte migration across the blood–retina barrier in uveoretinitis
Adhesion molecules involved in leukocyte–endothelial cell interactions
Appropriate adhesion molecule expression on both leukocytes and cells of the BRB is clearly important in enabling the migration of leukocytes into the inflamed retina.
108
85
58
61
94
37
].
79
40
93
60
19
67
84
].

Mechanisms of leukocyte subset migration into the retina
131
]. This can be followed by confocal microscopy of retinal wholemounts, which allows both the quantification of cells entering the retina and further immunostaining to reveal changes in phenotype of endothelial cells and trafficking leukocytes.
2
137
135
140
34
35
140
].
10
27
+
137
].
136
+
+
 dendritic cells that persisted within the retina for several days. Several striking contrasts between inflammatory monocyte and Th1 cell trafficking were observed. Monocyte rolling in inflamed venules was faster and CD62-L dependent rather than LFA-1 dependent. While PSGL-1 was found to play a role in regulating diapedesis to the inflammatory site, CD62-L was shown to have a key role in regulating recruitment of monocytes to the lymphoid tissue from the circulation during inflammation (manuscript submitted for publication). These observations reveal that different molecular mechanisms are involved in leukocyte subset adhesion to endothelium and migration into the tissues.

Mechanisms of blood–retina barrier breakdown in EAU
60
86
1
62
2
].
135
].
116
133
133
]. These studies are consistent with a major role for venule endothelium in leukocyte recruitment to the retina and imply that breakdown of the BRB in uveitis is an active event triggered by adherent leukocytes rather than a passive event driven solely by local cytokine microenvironment.

The role of chemokines in leukocyte migration across the BRB in EAU
91
111
36
71
115
8
107
109
22
111
].
28
28
31
51
51
51
29
41
42
51
], and cell surface expression of CCR5, CXCR3 and CCR2 on infiltrating cells was detected by immunohistochemistry (pers. comm. IJC).
30
30
].
31
127
].
39
39
117
].
136
136
]. However, evidence from further studies indicates that although CCR2 may improve the efficiency of monocyte transendothelial migration at the inflamed BRB, it is not essential for monocyte emigration at this site (manuscript in preparation).
106
112
123
−/−
112
125
125
]. Thus, reliance on CCR2 for recruitment of monocytes may vary depending on the particular inflammatory stimulus and the microenvironment that is generated.
55
25
81
47
118
55
123
]. In EAU, our studies to date indicate that CX3CR1 is not essential for the trafficking of monocytes into the inflamed retina (manuscript in preparation).


Conclusions and implications for design of novel therapies
Current treatment for uveitis is still dependent in the most part on systemic, non-specific immunosuppression. Additional therapies such as cyclosporin A, tacrolimus and rapamycin may act by interfering with the production and action of cytokines, particularly interleukin-2, targeting T cell function. Mycophenolate mofetil, an antimetabolite affecting purine synthesis, is also valuable. Other immunosuppressants such as azathioprine, cyclophosphamide and chlorambucil have severe side effects restricting their use. Blockade of TNF-α is also effective at least in the short term and now used clinically in different forms. Despite the usefulness of these therapies, they are all relatively non-specific, and in recent years, the quest for specific, tailored therapies for uveitis has been paramount.
3
54
]. Although different statins may have different effects in different diseases, they are proven safe drugs and provide attractive therapeutic options.
100
141
73
75
48
43
]. These drugs may have potential use in inflammatory conditions involving the BRB.


Open Access
 This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

References
1.
Abbott
NJ


Astrocyte–endothelial interactions and blood–brain barrier permeability
J Anat
2002
200
629
638

12162730


2.
Abbott
NJ

Ronnback
L

Hansson
E


Astrocyte–endothelial interactions at the blood–brain barrier
Nat Rev Neurosci
2006
7
41
53

16371949


3.
Adamson
P

Wilbourn
B

Etienne-Manneville
S

Calder
V

Beraud
E

Milligan
G

Couraud
PO

Greenwood
J


Lymphocyte trafficking through the blood–brain barrier is dependent on endothelial cell heterotrimeric G-protein signaling
FASEB J
2002
16
1185
1194

12153986


4.
Albini
TA

Wang
RC

Reiser
B

Zamir
E

Wu
GS

Rao
NA


Microglial stability and repopulation in the retina
Br J Ophthalmol
2005
89
901
903

15965175


5.
Ali
S

Palmer
ACV

Banerjee
B

Fritchley
SJ

Kirby
JA


Examination of the function of RANTES, MIP-1 alpha, and MIP-1 beta following interaction with heparin-like glycosaminoglycans
J Biol Chem
2000
275
11721
11727

10766793


6.
Alon
R

Feigelson
S


From rolling to arrest on blood vessels: leukocyte tap dancing on endothelial integrin ligands and chemokines at sub-second contacts
Semin Immunol
2002
14
93
104

11978081


7.
Bacon
K

Baggiolini
M

Broxmeyer
H

Horuk
R

Lindley
I

Mantovani
A

Matsushima
K

Murphy
P

Nomiyama
H

Oppenheim
J

Rot
A

Schall
T

Tsang
M

Thorpe
R

Damme
J

Wadhwa
M

Yoshie
O

Zlotnik
A

Zoon
K


Chemokine/chemokine receptor nomenclature
J Interferon Cytokine Res
2002
22
1067
1068

12433287


8.
Baggiolini
M

Dewald
B

Moser
B


Human chemokines: an update
Annu Rev Immunol
1997
15
675
705

9143704


9.
Bakker
AB

Hoek
RM

Cerwenka
A

Blom
B

Lucian
L

McNeil
T

Murray
R

Phillips
LH

Sedgwick
JD

Lanier
LL


DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming
Immunity
2000
13
345
353

11021532


10.
Banerjee
S

Savant
V

Scott
RA

Curnow
SJ

Wallace
GR

Murray
PI


Multiplex bead analysis of vitreous humor of patients with vitreoretinal disorders
Invest Ophthalmol Vis Sci
2007
48
2203
2207

17460280


11.
Cai
J

Jiang
WG

Ahmed
A

Boulton
M


Vascular endothelial growth factor-induced endothelial cell proliferation is regulated by interaction between VEGFR-2, SH-PTP1 and eNOS
Microvasc Res
2006
71
20
31

16337972


12.
Callahan
MK

Ransohoff
RM


Analysis of leukocyte extravasation across the blood–brain barrier: conceptual and technical aspects
Curr Allergy Asthma Rep
2004
4
65
73

14680625


13.
Campbell
JJ

Foxman
EF

Butcher
EC


Chemoattractant receptor cross talk as a regulatory mechanism in leukocyte adhesion and migration
Eur J Immunol
1997
27
2571
2578

9368612


14.
Campbell
M

Collery
R

McEvoy
A

Gardiner
TA

Stitt
AW

Brankin
B


Involvement of MAPKs in endostatin-mediated regulation of blood–retinal barrier function
Curr Eye Res
2006
31
1033
1045

17169842


15.
Caspi
RR


Ocular autoimmunity: the price of privilege?
Immunol Rev
2006
213
23
35

16972894


16.
Caspi
RR

Chan
C-C

Wiggert
B

Chader
GJ


The mouse as a model of experimental autoimmune uveoretinitis (EAU)
Curr Eye Res
1990
9
169
174

2384008


17.
Caspi
RR

Roberge
FG

Chan
C

Wiggert
B

Chader
GJ

Rozenszajn
LA

Lando
Z

Nussenblatt
RB


A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens
J Immunol
1988
140
1490
1495

3346541


18.
Caspi
RR

Silver
PB

Chan
C-C

Sun
B

Agarwal
RK

Wells
J

Oddo
S

Fujino
Y

Najafian
F

Wilder
RL


Genetic susceptibility to experimental autoimmune uveoretinitis in the rat is associated with an elevated Th1 response
J Immunol
1996
157
2668
2675

8805672


19.
Chakravarthy
U

Stitt
AW

McNally
J

Bailie
JR

Hoey
EM

Duprex
P


Nitric oxide synthase activity and expression in retinal capillary endothelial cells and pericytes
Curr Eye Res
1995
14
285
294

7541741


20.
Chan
JR

Hyduk
SJ

Cybulsky
MI


Chemoattractants induce a rapid and transient upregulation of monocyte alpha 4 integrin affinity for vascular cell adhesion molecule 1 which mediates arrest: an early step in the process of emigration
J Exp Med
2001
193
1149
1158

11369786


21.
Chen
J

Smith
LE


Retinopathy of prematurity
Angiogenesis
2007
10
133
140

17332988


22.
Chensue
SW


Molecular machinations: chemokine signals in host–pathogen interactions
Clin Microbiol Rev
2001
14
821
835

11585787


23.
Cinamon
G

Grabovsky
V

Winter
E

Franitza
S

Feigelson
S

Shamri
R

Dwir
O

Alon
R


Novel chemokine functions in lymphocyte migration through vascular endothelium under shear flow
J Leukoc Biol
2001
69
860
866

11404368


24.
Cinamon
G

Shinder
V

Alon
R


Shear forces promote lymphocyte migration across vascular endothelium bearing apical chemokines
Nat Immunol
2001
2
515
522

11376338


25.
Combadiere
C

Potteaux
S

Gao
JL

Esposito
B

Casanova
S

Lee
EJ

Debre
P

Tedgui
A

Murphy
PM

Mallat
Z


Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice
Circulation
2003
107
1009
1016

12600915


26.
Constantin
G

Majeed
M

Giagulli
C

Piccio
L

Kim
JY

Butcher
EC

Laudanna
C


Chemokines trigger immediate beta 2 integrin affinity and mobility changes: differential regulation and roles in lymphocyte arrest under flow
Immunity
2000
13
759
769

11163192


27.
Crane
IJ

Forrester
JV


Th1 and Th2 lymphocytes in autoimmune disease
Crit Rev Immunol
2005
25
75
102

15952931


28.
Crane
IJ

McKillop-Smith
S

Wallace
CA

Lamont
GR

Forrester
JV


Expression of the chemokines MIP-1a, MCP-1 and RANTES in experimental autoimmune uveitis
Invest Ophthalmol Vis Sci
2001
42
1547
1552

11381059


29.
Crane
IJ

Wallace
CA

McKillop-Smith
S

Forrester
JV


Control of chemokine production at the blood–retina barrier
Immunology
2000
101
426
433

11106948


30.
Crane
IJ

Xu
H

Manivannan
A

McKillop-Smith
S

Lamont
G

Wallace
C

Sharp
PF

Forrester
JV


Effect of anti-macrophage inflammatory protein-1a on leukocyte trafficking and disease progression in experimental autoimmune uveoretinitis
Eur J Immunol
2003
33
402
410

12645937


31.
Crane
IJ

Xu
H

Wallace
C

Manivannan
A

Mack
M

Liversidge
J

Marquez
G

Sharp
P

Forrester
JV


Involvement of CCR5 in the passage of Th1-type cells across the blood–retina barrier in experimental autoimmune uveitis
J Leukoc Biol
2006
79
435
443

16365158


32.
D’Amico
G

Frascaroli
G

Bianchi
G

Transidico
P

Doni
A

Vecchi
A

Sozzani
S

Allavena
P

Mantovani
A


Uncoupling of inflammatory chemokine receptors by IL-10: generation of functional decoys
Nat Immunol
2000
1
387
391

11062497


33.
Daniele
LL

Adams
RH

Durante
DE

Pugh
EN

Philp
NJ


Novel distribution of junctional adhesion molecule-C in the neural retina and retinal pigment epithelium
J Comp Neurol
2007
505
166
176

17853450


34.
DeGrendele
HC

Estess
P

Picker
LJ

Siegelman
MH


CD44 and its ligand hyaluronate mediate rolling under physiologic flow: a novel lymphocyte-endothelial cell primary adhesion pathway
J Exp Med
1996
183
1119
1130

8642254


35.
DeGrendele
HC

Estess
P

Siegelman
MH


Requirement for CD44 in activated T cell extravasation into an inflammatory site
Science
1997
278
672
675

9381175


36.
Devaney
JM

Greene
CM

Taggart
CC

Carroll
TP

O’Neill
SJ

McElvaney
NG


Neutrophil elastase up-regulates interleukin-8 via toll-like receptor 4
FEBS Lett
2003
544
129
132

12782302


37.
Devine
L

Lightman
SL

Greenwood
J


Role of LFA-1, ICAM-1, VLA-4 and VCAM-1 in lymphocyte migration across retinal pigment epithelial monolayers in vitro
Immunology
1996
88
456
462

8774365


38.
Dick
AD

McMenamin
PG

Korner
H

Scallon
BJ

Ghrayeb
J

Forrester
JV

Sedgwick
JD


Inhibition of tumour necrosis factor activity minimizes target organ damage in experimental autoimmune uveoretinitis despite quantitatively normal activated T cell traffic to the retina
Eur J Immunol
1996
26
1018
1025

8647162


39.
Diedrichs-Mohring
M

Nelson
PJ

Proudfoot
AEI

Thurau
SR

Wildner
G


The effect of the CC chemokine receptor antagonist Met-RANTES on experimental autoimmune uveitis and oral tolerance
J Neuroimmunol
2005
164
22
30

15921764


40.
Dua
HS

McKinnon
A

McMenamin
PG

Forrester
JV


Ultrastructural pathology of the ‘barrier sites’ in experimental autoimmune uveitis and experimental autoimmune pinealitis
Br J Ophthalmol
1991
75
391
397

1854690


41.
Elner
VM

Burnstine
MA

Strieter
RM

Kunkel
SL

Elner
SG


Cell-associated human retinal pigment epithelium interleukin-8 and monocyte chemotactic protein-1: immunochemical and in-situ hybridization analyses
Exp Eye Res
1997
65
781
789

9441701


42.
Elner
SG

DelMonte
D

Bian
ZM

Lukacs
NW

Elner
VM


Differential expression of retinal pigment epithelium (RPE) IP-10 and interleukin-8
Exp Eye Res
2006
83
374
379

16674942


43.
Emmelkamp
JM

Rockstroh
JK


CCR5 antagonists: comparison of efficacy, side effects, pharmacokinetics and interactions—review of the literature
Eur J Med Res
2007
12
409
417

17933722


44.
Engelhardt
B

Ransohoff
RM


The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms
Trends Immunol
2005
26
485
495

16039904


45.
Engelhardt
B

Wolburg
H


Mini-review: transendothelial migration of leukocytes: through the front door or around the side of the house?
Eur J Immunol
2004
34
2955
2963

15376193


46.
Erickson
KK

Sundstrom
JM

Antonetti
DA


Vascular permeability in ocular disease and the role of tight junctions
Angiogenesis
2007
10
103
117

17340211


47.
Feng
LL

Chen
SZ

Garcia
GE

Xia
YY

Siani
MA

Botti
P

Wilson
CB

Harrison
JK

Bacon
KB


3
CR1
Kidney Int
1999
56
612
620

10432400


48.
Feria
M

Diaz-Gonzalez
F


The CCR2 receptor as a therapeutic target
Expert Opin Ther Pat
2006
16
49
57

Feria M, Diaz-Gonzalez F (2006) The CCR2 receptor as a therapeutic target. Expert Opin Ther Pat 16:49–57 

49.
Forrester
JV


Pleyer
U

Zierhut
M

Behrens-Baumann
W


Autoimmunity and autoimmune diseases of the eye
Immuno-ophthalmology, Dev Ophthalmol
2000
Basel
Karger
167
185

Forrester JV (2000) Autoimmunity and autoimmune diseases of the eye. In: Pleyer U, Zierhut M, Behrens-Baumann W (eds) Immuno-ophthalmology, Dev Ophthalmol. Karger, Basel, pp 167–185 

50.
Forrester
JV

Liversidge
W

Dua
HS

Dick
A

Harper
F

McMenamin
PG


Experimental autoimmune uveoretinitis: a model system for immunointervention: a review
Curr Eye Res
1992
11
33
40

1358557


51.
Foxman
EF

Zhang
MF

Hurst
SD

Muchamuel
T

Shen
DF

Wawrousek
EF

Chan
CC

Gery
I


Inflammatory mediators in uveitis: differential induction of cytokines and chemokines in Th1-versus Th2-mediated ocular inflammation
J Immunol
2002
168
2483
2492

11859142


52.
Gardner
TW

Antonetti
DA

Barber
AJ

LaNoue
KF

Levison
SW


Diabetic retinopathy: more than meets the eye
Surv Ophthalmol
2002
47
Suppl 2
S253
S262

12507627


53.
Ge
S

Song
L

Pachter
JS


Where is the blood–brain barrier… really?
J Neurosci Res
2005
79
421
427

15635601


54.
Gegg
ME

Harry
R

Hankey
D

Zambarakji
H

Pryce
G

Baker
D

Adamson
P

Calder
V

Greenwood
J


Suppression of autoimmune retinal disease by lovastatin does not require Th2 cytokine induction
J Immunol
2005
174
2327
2335

15699169


55.
Geissmann
F

Jung
S

Littman
DR


Blood monocytes consist of two principal subsets with distinct migratory properties
Immunity
2003
19
71
82

12871640


56.
Giebel
SJ

Menicucci
G

McGuire
PG

Das
A


Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood–retinal barrier
Lab Invest
2005
85
597
607

15711567


57.
Greenwood
J


Mechanisms of blood–brain barrier breakdown
Neuroradiology
1991
33
95
100

2046916


58.
Greenwood
J

Calder
VL


Lymphocyte migration through cultured endothelial cell monolayers derived from the blood–retinal barrier
Immunology
1993
80
401
406

8288317


59.
Greenwood
J

Amos
CL

Walters
CE

Couraud
PO

Lyck
R

Engelhardt
B

Adamson
P


Intracellular domain of brain endothelial intercellular adhesion molecule-1 is essential for T lymphocyte-mediated signaling and migration
J Immunol
2003
171
2099
2108

12902516


60.
Greenwood
J

Howes
R

Lightman
S


The blood–retinal barrier in experimental autoimmune uveoretinitis. Leukocyte interactions and functional damage
Lab Invest
1994
70
39
52

8302017


61.
Greenwood
J

Wang
Y

Calder
VL


Lymphocyte adhesion and transendothelial migration in the central nervous system: the role of LFA-1, ICAM-1, VLA-4 and VCAM-1
off. Immunology
1995
86
408
415

Greenwood J, Wang Y, Calder VL (1995) Lymphocyte adhesion and transendothelial migration in the central nervous system: the role of LFA-1, ICAM-1, VLA-4 and VCAM-1. off. Immunology 86:408–415 

62.
Haseloff
RF

Blasig
IE

Bauer
HC

Bauer
H


In search of the astrocytic factor(s) modulating blood–brain barrier functions in brain capillary endothelial cells in vitro
Cell Mol Neurobiol
2005
25
25
39

15962507


63.
Hawkins
BT

Davis
TP


The blood–brain barrier/neurovascular unit in health and disease
Pharmacol Rev
2005
57
173
185

15914466


64.
Heil
M

Clauss
M

Suzuki
K

Buschmann
IR

Willuweit
A

Fischer
S

Schaper
W


Vascular endothelial growth factor (VEGF) stimulates monocyte migration through endothelial monolayers via increased integrin expression
Eur J Cell Biol
2000
79
850
857

11139149


65.
Hickey
WF


Basic principles of immunological surveillance of the normal central nervous system
Glia
2001
36
118
124

11596120


66.
Hickey
WF

Hsu
BL

Kimura
H


T-lymphocyte entry into the central nervous system
J Neurosci Res
1991
28
254
260

2033653


67.
Hoey
S

Grabowski
PS

Ralston
SH

Forrester
JV

Liversidge
J


Nitric oxide accelerates the onset and increases the severity of experimental autoimmune uveoretinitis through an IFN-gamma-dependent mechanism
J Immunol
1997
159
5132
5142

9366443


68.
Howard
OMZ

Dong
HF

Su
SB

Caspi
RR

Chen
X

Plotz
P

Oppenheim
JJ


Autoantigens signal through chemokine receptors: uveitis antigens induce CXCR3- and CXCR5-expressing lymphocytes and immature dendritic cells to migrate
Blood
2005
105
4207
4214

15713799


69.
Ishida
S

Usui
T

Yamashiro
K

Kaji
Y

Ahmed
E

Carrasquillo
KG

Amano
S

Hida
T

Oguchi
Y

Adamis
AP


VEGF164 is proinflammatory in the diabetic retina
Invest Ophthalmol Vis Sci
2003
44
2155
2162

12714656


70.
Ishida
S

Usui
T

Yamashiro
K

Kaji
Y

Amano
S

Ogura
Y

Hida
T

Oguchi
Y

Ambati
J

Miller
JW

Gragoudas
ES

Ng
YS

D’Amore
PA

Shima
DT

Adamis
AP


VEGF164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularization
J Exp Med
2003
198
483
489

12900522


71.
Janeway
CA

Medzhitov
R


Innate immune recognition
Annu Rev Immunol
2002
20
197
216

11861602


72.
Jha
P

Bora
PS

Bora
NS


The role of complement system in ocular diseases including uveitis and macular degeneration
Mol Immunol
2007
44
3901
3908

17768108


73.
Johnson
KP


Natalizumab (Tysabri) treatment for relapsing multiple sclerosis
Neurologist
2007
13
182
187

17622909


74.
Johnston
B

Butcher
EC


Chemokines in rapid leukocyte adhesion triggering and migration
Semin Immunol
2002
14
83
92

11978080


75.
Joshi
A

Bauer
R

Kuebler
P

White
M

Leddy
C

Compton
P

Garovoy
M

Kwon
P

Walicke
P

Dedrick
R


An overview of the pharmacokinetics and pharmacodynamics of efalizumab: a monoclonal antibody approved for use in psoriasis
J Clin Pharmacol
2006
46
10
20

16397279


76.
Kastelan
S

Zjacic-Rotkvic
V

Kastelan
Z


Could diabetic retinopathy be an autoimmune disease?
Med Hypotheses
2007
68
1016
1018

17125935


77.
Kenakin
T

Onaran
O


The ligand paradox between affinity and efficacy: can you be there and not make a difference?
Trends Pharmacol Sci
2002
23
275
280

12084633


78.
Kim
M

Carman
CV

Springer
TA


Bidirectional transmembrane signaling by cytoplasmic domain separation in integrins
Science
2003
301
1720
1725

14500982


79.
Kuppner
MC

Liversidge
J

McKillop-Smith
S

Lumsden
L

Forrester
JV


Adhesion molecule expression in acute and fibrotic sympathetic ophthalmia
Curr Eye Res
1993
12
923
934

8293668


80.
Leal
EC

Manivannan
A

Hosoya
K

Terasaki
T

Cunha-Vaz
J

Ambrosio
AF

Forrester
JV


Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood–retinal barrier breakdown in diabetic retinopathy
Invest Ophthalmol Vis Sci
2007
48
5257
5265

17962481


81.
Lesnik
P

Haskell
CA

Charo
IF


Decreased atherosclerosis in CX3CR1−/− mice reveals a role for fractalkine in atherogenesis
J Clin Invest
2003
111
333
340

12569158


82.
Ley
K

Laudanna
C

Cybulsky
MI

Nourshargh
S


Getting to the site of inflammation: the leukocyte adhesion cascade updated
Nat Rev Immunol
2007
7
678
689

17717539


83.
Liversidge
J

Forrester
JV


Experimental autoimmune uveitis (EAU): immunophenotypic analysis of inflammatory cells in chorio retinal lesions
Curr Eye Res
1988
7
1231
1241

3229134


84.
Liversidge
J

Forrester
JV


Marmor
MF

Wolfensberger
TJ


Regulation of immune responses by the retinal pigment epithelium
Retinal pigment epithelium, current aspects of function and disease
1999
Oxford
Oxford University Press
511
527

Liversidge J, Forrester JV (1999) Regulation of immune responses by the retinal pigment epithelium. In: Marmor MF, Wolfensberger TJ (eds) Retinal pigment epithelium, current aspects of function and disease. Oxford University Press, Oxford, pp 511–527 

85.
Liversidge
J

Sewell
HF

Forrester
JV


Interactions between lymphocytes and cells of the blood–retina barrier: mechanisms of T lymphocyte adhesion to human retinal capillary endothelial cells and retinal pigment epithelial cells in vitro
Immunology
1990
71
390
396

1980120


86.
Luna
JD

Chan
CC

Derevjanik
NL

Mahlow
J

Chiu
C

Peng
B

Tobe
T

Campochiaro
PA

Vinores
SA


Blood–retinal barrier (BRB) breakdown in experimental autoimmune uveoretinitis: comparison with vascular endothelial growth factor, tumor necrosis factor alpha, and interleukin-1beta-mediated breakdown
J Neurosci Res
1997
49
268
280

9260738


87.
Luscinskas
FW

Ma
S

Nusrat
A

Parkos
CA

Shaw
SK


The role of endothelial cell lateral junctions during leukocyte trafficking
Immunol Rev
2002
186
57
67

12234362


88.
Maharaj
AS

D’Amore
PA


Roles for VEGF in the adult
Microvasc Res
2007
74
100
113

17532010


89.
Maly
P

Thall
A

Petryniak
B

Rogers
CE

Smith
PL

Marks
RM

Kelly
RJ

Gersten
KM

Cheng
G

Saunders
TL

Camper
SA

Camphausen
RT

Sullivan
FX

Isogai
Y

Hindsgaul
O

Andrian
UH

Lowe
JB


The alpha(1,3)fucosyltransferase Fuc-TVII controls leukocyte trafficking through an essential role in L-, E-, and P-selectin ligand biosynthesis
Cell
1996
86
643
653

8752218


90.
Mandell
KJ

Berglin
L

Severson
EA

Edelhauser
HF

Parkos
CA


Expression of JAM-A in the human corneal endothelium and retinal pigment epithelium: localization and evidence for role in barrier function
Invest Ophthalmol Vis Sci
2007
48
3928
3936

17724169


91.
Mantovani
A


The chemokine system: redundancy for robust outputs
Immunol Today
1999
20
254
257

10354549


92.
Mantovani
A

Bonecchi
R

Locati
M


Tuning inflammation and immunity by chemokine sequestration: decoys and more
Nat Rev Immunol
2006
6
907
918

17124512


93.
McMenamin
PG

Forrester
JV

Steptoe
RJ

Dua
HS


Ultrastructural pathology of experimental autoimmune uveitis. Quantitative evidence of activation and possible high endothelial venule-like changes in retinal vascular endothelium
Lab Invest
1992
67
42
55

1625447


94.
Mesri
M

Liversidge
J

Forrester
JV


2
 and monoclonal antibody to lymphocyte function-associated antigen-1 differentially inhibit migration of T lymphocytes across microvascular retinal endothelial cells in rat
Immunology
1996
88
471
477

8774367


95.
Middleton
J

Neil
S

Wintle
J

Clark-Lewis
I

Moore
H

Lam
C

Auer
M

Hub
E

Rot
A


Transcytosis and surface presentation of IL-8 by venular endothelial cells
Cell
1997
91
385
395

9363947


96.
Middleton
J

Patterson
AM

Gardner
L

Schmutz
C

Ashton
BA


Leukocyte extravasation: chemokine transport and presentation by the endothelium
Blood
2002
100
3853
3860

12433694


97.
Moore
TC

Moore
JE

Kaji
Y

Frizzell
N

Usui
T

Poulaki
V

Campbell
IL

Stitt
AW

Gardiner
TA

Archer
DB

Adamis
AP


The role of advanced glycation end products in retinal microvascular leukostasis
Invest Ophthalmol Vis Sci
2003
44
4457
4464

14507893


98.
Muller
WA

Randolph
GJ


Migration of leukocytes across endothelium and beyond: molecules involved in the transmigration and fate of monocytes
J Leukoc Biol
1999
66
698
704

10577496


99.
Niederkorn
JY


See no evil, hear no evil, do no evil: the lessons of immune privilege
Nat Immunol
2006
7
354
359

16550198


100.
Norman
MU

Kubes
P


Therapeutic intervention in inflammatory diseases: a time and place for anti-adhesion therapy
Microcirculation
2005
12
91
98

15804977


101.
Oppenheim
JJ

Dong
HF

Plotz
P

Caspi
RR

Dykstra
M

Pierce
S

Martin
R

Carlos
C

Finn
O

Koul
O

Howard
OM


Autoantigens act as tissue-specific chemoattractants
J Leukoc Biol
2005
77
854
861

15917448


102.
Pachter
JS

Vries
HE

Fabry
Z


The blood–brain barrier and its role in immune privilege in the central nervous system
J Neuropathol Exp Neurol
2003
62
593
604

12834104


103.
Prendergast
RA

Iliff
CE

Coskuncan
NM

Caspi
RR

Sartani
G

Tarrant
TK

Lutty
GA

McLeod
DS


T cell traffic and the inflammatory response in experimental autoimmune uveoretinitis
Invest Ophthalmol Vis Sci
1998
39
754
762

9538882


104.
Proudfoot
AEI

Handel
TM

Johnson
Z

Lau
EK

LiWang
P

Clark-Lewis
I

Borlat
F

Wells
TNC

Kosco-Vilbois
MH


Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines
Proc Natl Acad Sci USA
2003
100
1885
1890

12571364


105.
Qaum
T

Xu
Q

Joussen
AM

Clemens
MW

Qin
W

Miyamoto
K

Hassessian
H

Wiegand
SJ

Rudge
J

Yancopoulos
GD

Adamis
AP


VEGF-initiated blood–retinal barrier breakdown in early diabetes
Invest Ophthalmol Vis Sci
2001
42
2408
2413

11527957


106.
Quinones
MP

Ahuja
SK

Jimenez
F

Schaefer
J

Garavito
E

Rao
A

Chenaux
G

Reddick
RL

Kuziel
WA

Ahuja
SS


Experimental arthritis in CC chemokine receptor 2-null mice closely mimics severe human rheumatoid arthritis
J Clin Invest
2004
113
856
866

15067318


107.
Rollins
BJ


Chemokines
Blood
1997
90
909
928

9242519


108.
Rosen
SD


Ligands for L-selectin: homing, inflammation, and beyond
Annu Rev Immunol
2004
22
129
156

15032576


109.
Rossi
D

Zlotnik
A


The biology of chemokines and their receptors
Annu Rev Immunol
2000
18
217
243

10837058


110.
Rot
A


Contribution of Duffy antigen to chemokine function
Cytokine Growth Factor Rev
2005
16
687
694

16054417


111.
Rot
A

Andrian
UH


Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells
Annu Rev Immunol
2004
22
891
928

15032599


112.
Serbina
NV

Pamer
EG


Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2
Nat Immunol
2006
7
311
317

16462739


113.
Shaw
SK

Bamba
PS

Perkins
BN

Luscinskas
FW


Real-time imaging of vascular endothelial-cadherin during leukocyte transmigration across endothelium
J Immunol
2001
167
2323
2330

11490021


114.
Silver
PB

Chan
C-C

Wiggert
B

Caspi
RR


The requirement for pertussis to induce EAU is strain-dependent: B10.RIII, but not B10. A mice develop EAU and Th1 responses to IRBP without pertussis treatment
Invest Ophthalmol Vis Sci
1999
40
2898
2905

10549650


115.
Smiley
ST

King
JA

Hancock
WW


Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4
J Immunol
2001
167
2887
2894

11509636


116.
Song
L

Pachter
JS


Monocyte chemoattractant protein-1 alters expression of tight junction-associated proteins in brain microvascular endothelial cells
Microvasc Res
2004
67
78
89

14709405


117.
Sonoda
KH

Sasa
Y

Qiao
H

Tsutsumi
C

Hisatomi
T

Komiyama
S

Kubota
T

Sakamoto
T

Kawano
YI

Ishibashi
T


Immunoregulatory role of ocular macrophages. The macrophages produce RANTES to suppress experimental autoimmune uveitis
J Immunol
2003
171
2652
2659

12928419


118.
Soriano
SG

Amaravadi
LS

Wang
YF

Zhou
H

Yu
GX

Tonra
JR

Fairchild-Huntress
V

Fang
Q

Dunmore
JH

Huszar
D

Pan
Y


Mice deficient in fractalkine are less susceptible to cerebral ischemia–reperfusion injury
J Neuroimmunol
2002
125
59
65

11960641


119.
Stein
JV

Cheng
G

Stockton
BM

Fors
BP

Butcher
EC

Andrian
UH


L-selectin-mediated leukocyte adhesion in vivo: microvillous distribution determines tethering efficiency, but not rolling velocity
J Exp Med
1999
189
37
50

9874562


120.
Streilein
JW


Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation
J Leukoc Biol
2003
74
179
185

12885934


121.
Streilein
JW

Ksander
BR

Taylor
AW


Immune deviation in relation to ocular immune privilege
J Immunol
1997
158
3557
3560

9103414


122.
Sun
B

Rizzo
LV

Sun
S-H

Chan
C-C

Wiggert
B

Wilder
RL

Caspi
RR


Genetic susceptibility to experimental autoimmune uveitis involves more than a predisposition to generate a T Helper-1-like or a T Helper-2-like response
J Immunol
1997
159
1004
1011

9218623


123.
Tacke
F

Alvarez
D

Kaplan
TJ

Jakubzick
C

Spanbroek
R

Llodra
J

Garin
A

Liu
JH

Mack
M

Rooijen
N

Lira
SA

Habenicht
AJ

Randolph
GJ


Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques
J Clin Invest
2007
117
185
194

17200718


124.
Tanaka
Y

Adams
DH

Shaw
S


Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes
Immunol Today
1993
14
111
115

8466625


125.
Tsou
CL

Peters
W

Si
Y

Slaymaker
S

Aslanian
AM

Weisberg
SP

Mack
M

Charo
IF


Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites
J Clin Invest
2007
117
902
909

17364026


126.
Vestweber
D


Molecular mechanisms that control endothelial cell contacts
J Pathol
2000
190
281
291

10685062


127.
Weber
C

Weber
KSC

Klier
C

Gu
S

Wank
R

Horuk
R

Nelson
PJ


h
+
 T cells
Blood
2001
97
1144
1146

11159551


128.
Wilkinson-Berka
JL


Vasoactive factors and diabetic retinopathy: vascular endothelial growth factor, cycoloxygenase-2 and nitric oxide
Curr Pharm Des
2004
10
3331
3348

15544519


129.
Worthylake
RA

Burridge
K


Leukocyte transendothelial migration: orchestrating the underlying molecular machinery
Curr Opin Cell Biol
2001
13
569
577

11544025


130.
Xanthou
G

Duchesnes
CE

Williams
TJ

Pease
JE


CCR3 functional responses are regulated by both CXCR3 and its ligands CXCL9, CXCL10 and CXCL11
Eur J Immunol
2003
33
2241
2250

12884299


131.
Xu
H

Manivannan
A

Goatman
K

Liversidge
J

Sharp
PF

Forrester
JV

Crane
I


Improved leukocyte tracking in mouse retinal and choroidal circulation
Exp Eye Res
2002
74
403
410

12014921


132.
Xu
H

Chen
M

Mayer
EJ

Forrester
JV

Dick
AD


Turnover of resident retinal microglia in the normal adult mouse
Glia
2007
55
1189
1198

17600341


133.
Xu
H

Dawson
R

Crane
IJ

Liversidge
J


Leukocyte diapedesis in vivo induces transient loss of tight junction protein at the blood–retina barrier
Invest Ophthalmol Vis Sci
2005
46
2487
2494

15980240


134.
Xu
H

Dawson
R

Forrester
JV

Liversidge
J


Identification of novel dendritic cell populations in normal mouse retina
Invest Ophthalmol Vis Sci
2007
48
1701
1710

17389502


135.
Xu
H

Forrester
JV

Liversidge
J

Crane
IJ


Leukocyte trafficking in experimental autoimmune uveitis: breakdown of blood–retinal barrier and upregulation of cellular adhesion molecules
Invest Ophthalmol Vis Sci
2003
44
226
234

12506079


136.
Xu
H

Manivannan
A

Dawson
R

Crane
IJ

Mack
M

Sharp
P

Liversidge
J


Differentiation to the CCR2+ inflammatory phenotype in vivo is a constitutive, time-limited property of blood monocytes and is independent of local inflammatory mediators
J Immunol
2005
175
6915
6923

16272351


137.
Xu
H

Manivannan
A

Goatman
KA

Jiang
HR

Liversidge
J

Sharp
PF

Forrester
JV

Crane
IJ


Reduction in shear stress, activation of the endothelium, and leukocyte priming are all required for leukocyte passage across the blood–retina barrier
J Leukoc Biol
2004
75
224
232

14634055


138.
Xu
H

Manivannan
A

Jiang
HR

Liversidge
J

Sharp
PF

Forrester
JV

Crane
IJ


Recruitment of IFN-gamma-producing (Th1-like) cells into the inflamed retina in vivo is preferentially regulated by P-selectin glycoprotein ligand 1:P/E-selectin interactions
J Immunol
2004
172
3215
3224

14978129


139.
Xu
H

Manivannan
A

Liversidge
J

Sharp
PF

Forrester
JV

Crane
IJ


Requirements for passage of T lymphocytes across non-inflamed retinal microvessels
J Neuroimmunol
2003
142
47
57

14512163


140.
Xu
H

Manivannan
A

Liversidge
J

Sharp
PF

Forrester
JV

Crane
IJ


Involvement of CD44 in leukocyte trafficking at the blood–retinal barrier
J Leukoc Biol
2002
72
1133
1141

12488494


141.
Yonekawa
K

Harlan
IJ


Targeting leukocyte integrins in human diseases
J Leukoc Biol
2005
77
129
140

15548573


142.
Zernecke
A

Weber
KSC

Erwig
LP

Kluth
DC

Schroppel
B

Rees
AJ

Weber
C


Combinatorial model of chemokine involvement in glomerular monocyte recruitment: role of CXC chemokine receptor 2 in infiltration during nephrotoxic nephritis
J Immunol
2001
166
5755
5762

11313419


143.
Zlotnik
A

Yoshie
O


Chemokines: a new classification system and their role in immunity
Immunity
2000
12
121
127

10714678





